期刊档案 · Medicine-General Medicine
Mayo Clinic Proceedings Innovations Quality Outcomes
ISSN 2542-4548 · Elsevier · United States
Mayo Clinic Proceedings Innovations Quality Outcomes 影响因子 4.5（官网公布），完全开放获取，APC 约 3,000 美元，近 24 个月 48 篇文章投稿到接收中位 112 天，2025 年发文 81 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Mayo Clinic Proceedings Innovations Quality Outcomes 由 Elsevier 出版。按 OpenAlex 近年发文统计，该刊主要发表 Diverse Scientific and Economic Studies、COVID-19 Clinical Research Studies、Ferroelectric and Negative Capacitance Devices 等主题的论文，这 3 个主题约占 29.2%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Mayo Clinic Proceedings: Innovations, Quality & Outcomes (MCP:IQ&O) is an open access, digital (online) journal, sponsored by Mayo Clinic and belongs to the Mayo Clinic Proceedings family of journals. MCP:IQ&O is focused on promoting human well-being by offering a trusted knowledge platform encompassing innovations, quality, and outcomes research across the entire spectrum of the health care ecosystem.MCP:IQ&O publishes original research, reviews, case series, clinical content, editorials, commentaries, brief reports, special articles, and other short items.The content of MCP:IQ&O is organized along two broad themes: Measure What Matters and Health Care Futurology.Measure What Matters: Includes content related to research questions, quality improvement projects, clinical investigations, and narrative and systematic reviews by experts that crisply and pragmatically address current challenges faced by health care system stakeholders including clinicians, educators, system administrators, policy makers, industry, and global health systems.Health Care Futurology: As a combination of written and audio-visual content, Health Care Futurology provides a bold and unconventional subject matter platform to health care ecosystem stakeholders. Clinicians, educators, health policy experts, advocacy groups, health-system administrators and members of the biotech, pharma, and medical device industry can meaningfully engage in discussion, dialogue, and opinion writing on challenging, controversial, and disruptive topics including past failures and lessons learned that are expected to shape future health care.Submissions from all medical and surgical specialties are welcome as long as they are relevant to a broad audience and address the current and future challenges of the field.Domains of special and particular interest for MCP:IQ&O include:Addressing the burden of chronic diseases (for example, Lifestyle Medicine)Global HealthBelonging across the full spectrum of health care ecosystem (patients, care providers, systems, nations, and the global community)Ethical and policy issues pertaining to the biotech and infotech revolution and its interface with medicineUse of new methodology in clinical researchBioinformatics, telehealth, and health-systems researchHealth care economics
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Medicine-General Medicine
主编 Taimur Sher出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 28、尼日利亚 3、瑞士 2、卡塔尔 1（共 34 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance15.3%
- COVID-19 Clinical Research StudiesMedicine7%
- Ferroelectric and Negative Capacitance DevicesEngineering7%
- Big Data and Digital EconomyComputer Science7%
- Human auditory perception and evaluationEngineering6.5%
- Educational Robotics and EngineeringComputer Science6.3%
- COVID-19 and healthcare impactsMedicine5.2%
- Healthcare professionals’ stress and burnoutHealth Professions3.9%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 4.5出版商官网 ·
- CiteScore 2026-06
- 5.7LetPub ·
- CiteScore（出版商公布）
- 5.7出版商官网 ·
- SJR 2026-06
- 0.89LetPub ·
- SNIP 2026-06
- 1.33LetPub ·
- h-index
- 42OpenAlex ·
- i10-index
- 290OpenAlex ·
- 两年平均被引
- 4.96OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 61LetPub ·
逐年发文量 OpenAlex 统计 · 累计 806 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 59 | 59 | 1 |
| 2025 | 81 | 81 | 84 |
| 2024 | 79 | 79 | 1,001 |
| 2023 | 70 | 70 | 323 |
| 2022 | 74 | 74 | 935 |
| 2021 | 137 | 137 | 2,145 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
112 天投稿到接收中位数 · P25–P75 69 天 – 144 天
- 接收到上线
- 中位数 33 天（48 篇）
- 投稿到上线
- 中位数 147 天
- 样本
- 48 篇有投稿与接收日期的文章（窗口内共 128 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 12 WeeksLetPub ·
- 投稿到首次决定
- 10 天出版商官网 ·
- 外审后首次决定
- 49 天出版商官网 ·
- 投稿到接收
- 90 天出版商官网 ·
- 投稿到发表（期刊自报）
- 约 18 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 3,000 | 有 | CC BY、CC BY-NC-ND | |
| OpenAlex | USD 3,000 / EUR 2,810 / GBP 2,400 / JPY 372,090 | — | — | |
| LetPub | USD 3,000 | 有 | — | |
| 出版商官网 | USD 3,000 / USD 1,000 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 250 词
- 参考文献格式
- AMA 格式
- 稿件模板
- 提供 Word 模板
- 图文摘要
- 可选
- 投稿信（Cover letter）
- 必须提供
接收的文章类型15 种，含篇幅限制
- brief reportsOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- case reportstyle and to abridge them if necessary. Case Reports Case Reports should be approximately 800 to 1800 words (up to 7 typed, double-spaced pages). Case reports m…正文 ≤ 1,800 词 · 图表 ≤ 2
- case reportsOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- commentariesOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- commentaryCommentaries are intended to offer expert insights into important or controversial topics related to clinical medicine, medical economics, governmental policy, …未说明篇幅
- editorialSubmission of Editorials is by invitation from, or prior arrangement with, the Editorial Board. Most Editorials will comment on other material (eg, an innovativ…未说明篇幅
- editorialsOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- letters to the editorOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- original articleThese include prospective clinical trials, laboratory research, retrospective clinical analyses (eg, case series), meta-analyses, and related research. Priority…未说明篇幅
- original articlesOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- review articleThese consist of a critical assessment of literature and existing data. Priority for publication is given to topics with relevance to the clinical care of patie…未说明篇幅
- review articlesOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- solicited reviewsOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- special articlesOriginal Articles Review Articles Solicited Reviews Special Articles Commentaries Brief Reports Editorials Letters to the Editor Case Reports未说明篇幅
- systematic reviewGuidelines for the most frequent types of articles submitted to the journal are summarized below. Specific limits for word count, references, tables, and figure…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、预印本、自存档
- AI 使用 Declaration of Generative AI in Scientific Writing
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Authorship
所有作者应在对研究的构思与设计或数据获取与分析、文章起草或重要内容修改、最终版本批准以及对工作各方面负责这四项中均做出实质性贡献。 模型中文摘要
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted and (4) agree to be accountable for all aspects of the work in ensuring tha…
原文 ↗出版商官网 ·- 利益冲突 Potential Financial and Other Competing Interests
所有作者必须披露任何可能不当影响其工作的财务和个人关系，并在稿件文件和提交系统中两处披露潜在竞争利益。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any potential competing inte…
原文 ↗出版商官网 ·- 数据可用性 Data Sharing Policy
目前要求作者说明数据是否共享，并在无法共享数据时提供解释。 模型中文摘要
At this time authors are asked to state if data will be shared and provide an explanation if data cannot be shared.Changes/Additions to Published ArticlesWhen an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify the journal editor or publisher, and cooperate with the editor to correct or retract the paper. Please see …
原文 ↗出版商官网 ·- 许可与版权 Copyright
文章被接受后，作者将被要求填写期刊出版协议。 模型中文摘要
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. More information.
原文 ↗出版商官网 ·- 开放获取 Open Access
该期刊的文章出版费（APC）为3000美元（不含税）。 模型中文摘要
Article Publishing Charge (APC): USD 3,000 (excluding taxes). Review this journal’s open access policy.
原文 ↗出版商官网 ·- 同行评审 Peer Review Process and Confidentiality
该期刊采用单盲同行评审流程，审稿人身份不向作者或其他审稿人披露。 模型中文摘要
Mayo Clinic Proceedings: Innovations, Quality & Outcomes uses a single anonymized review process. Reviewer identities are not, and should not be, disclosed to the authors or other reviewers. In addition, authors should not contact those whom they presume to be reviewers of their manuscript. All contributions are initially assessed by the Editor-in-Chief for suitability for the journal, and may ass…
原文 ↗出版商官网 ·- 预印本 Preprint Servers
该期刊考虑曾在预印本服务器上发布的论文，但作者须在投稿时在投稿信中确认预印本存档情况，且论文不应在投稿同时或之后发布到预印本服务器。 模型中文摘要
In alignment with Elsevier's Sharing Policy (https://www.elsevier.com/about/policies/sharing), we will consider papers previously posted on preprint servers such as arXiv, bioRxiv, ChemRxiv, and SSRN. At submission, authors must acknowledge, in the cover letter, the preprint server deposit, including the date of deposition, and provide any associated URLs or DOIs. Papers should not be posted to a …
原文 ↗出版商官网 ·- 自存档 Embargo
已接受稿件的内容和发表日期信息保密，在在线发表前不得出现在任何媒体上。 模型中文摘要
All information regarding the content and publication date of accepted manuscripts is confidential. Information contained in or about accepted articles cannot appear in any media outlet (print, broadcast, or electronic) until online publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- 出版国家或地区
- United States
- 出版语言
- English
- ISSN
- 2542-4548
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Mayo Clinic Proceedings Innovations Quality Outcomes 的常见问题
Mayo Clinic Proceedings Innovations Quality Outcomes 的影响因子是多少？
期刊官网公布的影响因子为 4.5，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 5.7，h-index 为 42。
Mayo Clinic Proceedings Innovations Quality Outcomes 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）48 篇已发表文章登记的日期，投稿到接收的中位数为 112 天（四分位 69–144 天）；投稿社区反馈的平均审稿速度为约 12 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Mayo Clinic Proceedings Innovations Quality Outcomes 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；参考文献格式：AMA 格式；稿件模板：提供 Word 模板；图文摘要：可选；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Mayo Clinic Proceedings Innovations Quality Outcomes 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 34 位编委中，没有中国大陆学者；人数最多的国家是 美国（28 位）、尼日利亚（3 位）、瑞士（2 位）。统计按编委会页面列出的机构国家计，仅供参考。
Mayo Clinic Proceedings Innovations Quality Outcomes 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Mayo Clinic Proceedings Innovations Quality Outcomes 被 ESCI、Scopus、DOAJ 收录。
Mayo Clinic Proceedings Innovations Quality Outcomes 是开放获取期刊吗？版面费多少？
Mayo Clinic Proceedings Innovations Quality Outcomes 为完全开放获取。APC 约 3,000 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。